Hsing-Ju Tsai

Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors

Danyan Xu, Ning Li, Yuxia He et al. · Proceedings of the National Academy of Sciences · 2006 · 230 citations · Full text

Soluble Epoxide Hydrolase: A Novel Therapeutic Target in Stroke

Wenri Zhang, Ines P. Koerner, Ruediger Noppens et al. · Journal of Cerebral Blood Flow & Metabolism · 2007 · 200 citations · Full text

Lipid Peroxidation, Pharmacotherapy, Cerebral Vascular Regulation +17

Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance

A. R. Luria, Ahmed Bettaieb, Yannan Xi et al. · Proceedings of the National Academy of Sciences · 2011 · 150 citations · Full text

Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model

Arzu Ulu, Benjamin B. Davis, Hsing-Ju Tsai et al. · Journal of Cardiovascular Pharmacology · 2008 · 122 citations · Full text

Vascular Disease, Hyperlipidemia, Oxidative Stress +18

Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection

Alexis N. Simpkins, R. Daniel Rudic, Derek A. Schreihofer et al. · American Journal Of Pathology · 2009 · 109 citations · Full text

Social Sciences, Cerebral Vascular Regulation, Neurovascular Disease +16